Literature DB >> 17115422

Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus.

Chung-Ming Huang1, An-Ping Huo, Chang-Hai Tsai, Chi-Lan Chen, Fuu-Jen Tsai.   

Abstract

The purpose of this study was to determine whether interleukin (IL)-6 and IL-8 gene polymorphisms were markers of susceptibility to or severity of systemic lupus erythematosus (SLE) in Chinese patients. The study included 150 Chinese patients with SLE. A total of 130 unrelated healthy individuals living in central Taiwan served as control subjects. Polymorphisms of the IL-6 and IL-8 gene were typed from genomic DNA. The genotypes, allelic frequencies, and carriage rates were compared between SLE patients and control subjects. The relationship between allelic frequencies and clinical manifestations of 135 SLE patients was evaluated. There were no statistically significant differences in IL-6 and IL-8 gene polymorphisms between the SLE and control groups (chi-squared test, P=0.53, chi(2)=1.27 and P=0.44, chi(2)=1.62, respectively). In addition, there was no significant association between the two groups in allelic frequency of IL-6 and IL-8 (P=0.89 and P=0.26, respectively). We also did not detect any association between the IL-6 and IL-8 genotype and clinical or laboratory profiles in SLE patients. The results suggest that the IL-6 and IL-8 gene polymorphisms are not related to SLE. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115422      PMCID: PMC6807478          DOI: 10.1002/jcla.20151

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  24 in total

1.  Expression of interleukin-8 in human glomerulonephritis.

Authors:  T Sekikawa; N Kashihara; K Maruyama; M Satoh; K Okamoto; K Kanao; Y Maeshima; H Sugiyama; Y Yamasaki; H Makino
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1998-02

2.  Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation.

Authors:  C F Terry; V Loukaci; F R Green
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

3.  Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis.

Authors:  M Linker-Israeli; R J Deans; D J Wallace; J Prehn; T Ozeri-Chen; J R Klinenberg
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

4.  Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression.

Authors:  M Linker-Israeli; D J Wallace; J Prehn; D Michael; M Honda; K D Taylor; M Paul-Labrador; N Fischel-Ghodsian; P A Fraser; J R Klinenberg
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

5.  Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia.

Authors:  B J M Ripley; B Goncalves; D A Isenberg; D S Latchman; A Rahman
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

6.  Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides.

Authors:  F A Houssiau; J P Devogelaer; J Van Damme; C N de Deuxchaisnes; J Van Snick
Journal:  Arthritis Rheum       Date:  1988-06

7.  Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8.

Authors:  N Mukaida; M Shiroo; K Matsushima
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

Review 8.  IL-6 in autoimmune disease and chronic inflammatory proliferative disease.

Authors:  Katsuhiko Ishihara; Toshio Hirano
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

9.  A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis.

Authors:  Brad H Rovin; Ling Lu; Xiaolan Zhang
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

10.  Systemic autoimmune disease arises from polyclonal B cell activation.

Authors:  D M Klinman; A D Steinberg
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  A meta-analysis of the association of IL-6 -174 G/C and -572 G/C polymorphisms with systemic lupus erythematosus risk.

Authors:  Zaixing Yang; Yan Liang; Baodong Qin; Renqian Zhong
Journal:  Rheumatol Int       Date:  2013-09-07       Impact factor: 2.631

2.  Interleukin (IL)-1beta, IL-1 receptor antagonist, IL-6, IL-8, IL-10, and tumor necrosis factor alpha gene polymorphisms in patients with febrile seizures.

Authors:  I-Ching Chou; Wei-De Lin; Chung-Hsing Wang; Chang-Hai Tsai; Tsai-Chung Li; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.

Authors:  Esmaeil Moazemi Godarzi; Eskandar Kamali Sarvestani; Elham Aflaki; Zahra Amirghofran
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

4.  Interferon gamma and Interleukin 10 polymorphisms in Brazilian patients with systemic lupus erythematosus.

Authors:  Hildson Dornelas Angelo da Silva; Alex Paulino da Silva; Helker Albuquerque da Silva; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

Review 5.  Genetic risk factors of systemic lupus erythematosus in the Malaysian population: a minireview.

Authors:  Hwa Chia Chai; Maude Elvira Phipps; Kek Heng Chua
Journal:  Clin Dev Immunol       Date:  2011-09-20

6.  A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE.

Authors:  Johanna K Sandling; Sophie Garnier; Snaevar Sigurdsson; Chuan Wang; Gunnel Nordmark; Iva Gunnarsson; Elisabet Svenungsson; Leonid Padyukov; Gunnar Sturfelt; Andreas Jönsen; Anders A Bengtsson; Lennart Truedsson; Catharina Eriksson; Solbritt Rantapää-Dahlqvist; Anders Mälarstig; Rona J Strawbridge; Anders Hamsten; Lindsey A Criswell; Robert R Graham; Timothy W Behrens; Maija-Leena Eloranta; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen
Journal:  Eur J Hum Genet       Date:  2010-12-22       Impact factor: 4.246

Review 7.  Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

Authors:  Hua Su; Chun-Tao Lei; Chun Zhang
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

8.  Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus.

Authors:  Maria Hristova; Lyubomir Dourmishev; Zornitsa Kamenarska; Svetla Nikolova; Radka Kaneva; Anton Vinkov; Marta Baleva; Daniela Monova; Vanio Mitev
Journal:  Biomed Res Int       Date:  2013-09-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.